VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.3252
-0.0088 (-2.63%)
At close: Aug 25, 2025, 4:00 PM
0.3275
+0.0023 (0.71%)
After-hours: Aug 25, 2025, 7:25 PM EDT

VYNE Therapeutics Stock Forecast

VYNE's stock price has decreased by -82.61% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for VYNE Therapeutics stock has a target of 8.00, which predicts a 2,360.02% increase from the current stock price of 0.33.

Price Target: $8.00 (+2,360.02%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$8.00$8.00$8.00$8.00
Change+2360.0%+2360.0%+2360.0%+2360.0%
* Price targets were last updated on Nov 18, 2024.

Analyst Ratings

The average analyst rating for VYNE Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy222211
Buy000000
Hold000011
Sell000000
Strong Sell000000
Total222222

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aJul 30, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$5.75$4.5
Strong BuyMaintains$5.75$4.5+1,283.76%Apr 25, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.75
Strong BuyReiterates$5.75+1,668.14%Mar 6, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.75
Strong BuyReiterates$5.75+1,668.14%Feb 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.75
Strong BuyReiterates$5.75+1,668.14%Jan 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
714.00K
from 501.00K
Increased by 42.51%
Revenue Next Year
459.00K
from 714.00K
Decreased by -35.71%
EPS This Year
-1.05
from -0.94
EPS Next Year
-0.75
from -1.05
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
20.99M931.00K477.00K424.00K501.00K714.00K459.00K-
Revenue Growth
4,638.83%-95.57%-48.77%-11.11%18.16%42.51%-35.71%-
EPS
-141.90-25.65-7.28-2.78-0.94-1.05-0.75-0.65
EPS Growth
--------
Forward PE
--------
No. Analysts
-----643
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High840,000945,000n/a
Avg714,000459,000n/a
Low588,000n/an/a

Revenue Growth

Revenue Growth20252026202720282029
High
67.7%
32.4%
-
Avg
42.5%
-35.7%
-
Low
17.4%
--

EPS Forecast

EPS20252026202720282029
High-0.87-0.62-0.67
Avg-1.05-0.75-0.65
Low-1.32-0.86-0.63

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.